Clinton Group’s Pfizer PFE Stock Holding History

Clinton Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$909K	Buy	+21,740	New	+$837K	0.33%	88
2018 Q1	–	Sell	-38,006	Closed	-$1.31M	–	458
2017 Q4	$1.31M	Buy	+38,006	New	+$1.3M	0.11%	232
2015 Q4	–	Sell	-8,133	Closed	-$242K	–	829
2015 Q3	$242K	Sell	8,133 -51,500	-86%	-$1.65M	0.02%	594
2015 Q2	$1.9M	Buy	+59,633	New	+$1.94M	0.27%	123
2015 Q1	–	Sell	-9,728	Closed	-$288K	–	581
2014 Q4	$288K	Buy	+9,728	New	+$279K	0.09%	353
2014 Q2	–	Sell	-20,191	Closed	-$615K	–	400
2014 Q1	$615K	Buy	+20,191	New	+$602K	0.23%	129

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Clinton Group's PFE Position: Q3 2018 in Review

Clinton Group opened a new position in Pfizer (PFE) in Q3 2018: 21,740 shares worth $909K. The stake represents 0.33% of the portfolio and ranks #88 among its holdings. This is a return to the name: Clinton Group previously reported a position in PFE as recently as Q4 2017.

Clinton Group first reported a position in PFE in Q1 2014 and has held it in 6 quarters since. The position peaked at $1.9M in Q2 2015. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

Clinton Group held 21,740 shares of Pfizer worth $909K as of Q3 2018.
Pfizer was a new Clinton Group position in Q3 2018.
Pfizer made up 0.33% of Clinton Group's portfolio in Q3 2018, its #88 holding.
Clinton Group first reported a position in Pfizer in Q1 2014 and has held it in 6 quarters since.
Clinton Group's Pfizer position peaked at $1.9M in Q2 2015.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.